Maciej Juryńczyk
About
In The Last Decade
Maciej Juryńczyk
27 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Pathology and Forensic Medicine 1.3k
- Neurology 1.1k
- Rheumatology 549
- Molecular Biology 261
- Immunology 222
Countries citing papers authored by Maciej Juryńczyk
This map shows the geographic impact of Maciej Juryńczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Juryńczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Juryńczyk more than expected).
Fields of papers citing papers by Maciej Juryńczyk
This network shows the impact of papers produced by Maciej Juryńczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Juryńczyk. The network helps show where Maciej Juryńczyk may publish in the future.
Co-authorship network of co-authors of Maciej Juryńczyk
This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Juryńczyk. A scholar is included among the top collaborators of Maciej Juryńczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Juryńczyk. Maciej Juryńczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 2 | |
| 4 | 40 | |
| 5 | 6 | |
| 6 | 9 | |
| 7 | 7 | |
| 8 | 16 | |
| 9 | Clinical presentation and prognosis in MOG-antibody disease: a UK study (vol 140, pg 12, 2017) | 2 |
| 10 | 43 | |
| 11 | 176 | |
| 12 | Clinical presentation and prognosis in MOG-antibody disease: a UK study breakdown → | 481 |
| 13 | 35 | |
| 14 | 126 | |
| 15 | 31 | |
| 16 | 67 | |
| 17 | 70 | |
| 18 | 55 | |
| 19 | 40 | |
| 20 | 75 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.